-+ 0.00%
-+ 0.00%
-+ 0.00%

Healthcare Triangle faces Nasdaq delisting after failing $1 minimum bid price rule

PUBT·10/02/2026 21:22:02
Healthcare Triangle faces Nasdaq delisting after failing $1 minimum bid price rule
  • Healthcare Triangle received a Nasdaq notice on Oct. 1, 2026 for failing the $1.00 minimum bid price rule.
  • Nasdaq issued a staff delisting determination, citing ineligibility for a cure period due to reverse splits totaling 1-for-14,940.
  • Absent an appeal by Oct. 8, trading would be suspended at the open on Oct. 12, followed by a Form 25-NSE filing.
  • The company plans to request a hearings panel review, which would stay suspension pending a decision.
  • Management expects to present a compliance plan that could include another reverse stock split.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthcare Triangle Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-106533), on October 02, 2026, and is solely responsible for the information contained therein.